Preload Image
Preload Image
Report Store mobile icon
Global Biological Drugs Market Growth 2024-2030

Global Biological Drugs Market Growth 2024-2030

2024

Global Biological Drugs Market Growth 2024-2030

The global Biological Drugs market was valued at US$ 277.6 billion in 2023, reflecting growing demand in the pharmaceutical industry.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global biological drugs market, also known as the biologics market, encompasses pharmaceutical products derived from living organisms or their components, utilizing advanced biotechnological processes. Unlike traditional chemical drugs synthesized through chemical reactions, biological drugs are large, complex molecules often produced using genetically modified cells. These drugs include monoclonal antibodies, vaccines, recombinant proteins, gene therapies, and RNA interference (RNAi) therapies. Due to their high specificity and ability to target particular proteins or pathways in the body, biological drugs are used to treat a wide range of medical conditions, such as cancer, autoimmune diseases, genetic disorders, and infectious diseases. The global biologics market was valued at USD 461.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2023 to 2030. This growth is driven by the rising burden of chronic diseases, advancements in personalized medicine, and the approval of several disease-modifying therapies. The development of mRNA-based vaccines, such as Pfizer's Comirnaty for COVID-19, has further expanded the market, paving the way for similar vaccines targeting other diseases. The market is also influenced by the increasing aging population, which leads to a higher prevalence of age-related diseases, and the growing demand for targeted and effective treatments. Despite the high cost of biological drugs and regulatory challenges, the market continues to thrive due to ongoing research and development, technological advancements, and the introduction of biosimilars that offer cost-effective alternatives. The global biological drugs market is poised for substantial growth, driven by the need for innovative treatments and the expanding healthcare infrastructure.

According to Publisher, the global Biological Drugs market size was valued at US$ 277550 million in 2023. With growing demand in downstream market, the Biological Drugs is forecast to a readjusted size of US$ 491510 million by 2030 with a CAGR of 8.5% during review period. Two significant challenges facing the global biological drugs market are the high cost of development and production and regulatory complexities. Developing biological drugs involves extensive research, clinical trials, and advanced manufacturing processes, which are costly and time-consuming. These high costs can limit market entry for smaller companies and increase the price of the final product, making it less accessible to patients. Additionally, the regulatory landscape for biological drugs is complex and varies across different regions. Obtaining approval from regulatory bodies like the FDA or EMA requires rigorous testing and compliance with stringent guidelines, which can delay market entry and increase development costs. Furthermore, the emergence of biosimilars—generic versions of biological drugs—poses a competitive threat, as they offer similar therapeutic benefits at a lower cost. This competition can drive down prices and profit margins for original biologic products. Addressing these challenges requires strategic investments in research and development, efficient regulatory navigation, and the development of cost-effective production methods to ensure the sustainability and growth of the global biological drugs market.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The global biological drugs market is segmented by type into several key categories, each serving distinct therapeutic needs. Monoclonal antibodies (MABs) are widely used for their ability to target specific antigens, making them effective in treating cancers and autoimmune diseases. Recombinant proteins are genetically engineered proteins used in various therapies, including growth factors and clotting factors. Antisense and RNAi Therapies utilize small pieces of nucleic acids to interfere with gene expression, offering potential treatments for genetic disorders and viral infections. Gene therapies involve the introduction, removal, or alteration of genetic material within a patient's cells to treat diseases at the genetic level. mRNA-based vaccines, such as those developed for COVID-19, represent a breakthrough in vaccine technology, providing rapid development and high efficacy. Each type of biological drug plays a crucial role in advancing medical treatments, addressing unmet needs, and improving patient outcomes. The continuous advancements in biotechnological research and development highlight the importance of these diverse types in meeting the evolving demands of the global healthcare market.

The global biological drugs market is segmented by application into several key areas, each addressing different healthcare needs. Cancer is a major application segment, with biological drugs such as monoclonal antibodies and gene therapies playing a crucial role in targeted cancer treatments. Infectious diseases utilize biological drugs for vaccines and antiviral therapies, offering effective prevention and treatment options. Autoimmune diseases benefit from biological drugs that modulate the immune system, providing relief for conditions like rheumatoid arthritis and multiple sclerosis. Other applications include treatments for genetic disorders, growth hormone deficiencies, and blood disorders, among others. Each application segment underscores the versatility and indispensability of biological drugs in addressing a wide range of medical conditions, driving innovation and improving patient outcomes. The continuous advancements in biotechnological research and development highlight the importance of these diverse applications in meeting the evolving demands of the global healthcare market.

The regional analysis of the global biological drugs market reveals distinct trends and growth patterns across different geographical areas, highlighting its critical role in supporting regional industrial and economic development. The Asia-Pacific region stands out as the largest market, driven by rapid industrialization, urbanization, and extensive infrastructure development in countries like China, India, and South Korea. China's position as the world's largest producer and consumer of copper significantly bolsters this dominance. In North America, steady demand is primarily driven by the construction and automotive sectors, with the U.S. government's focus on revitalizing domestic manufacturing and infrastructure development programs enhancing the market. However, the region faces challenges such as fluctuating raw material prices and geopolitical tensions affecting supply chains. The European market is notable for its emphasis on sustainable construction practices and advanced steel technologies, with significant contributions from countries like Germany, France, and the U.K. Despite stringent environmental regulations, the need for continuous innovation drives market growth. Emerging markets in the Middle East, Africa, and Latin America are experiencing growth due to increasing infrastructure projects and industrial activities, presenting opportunities for expansion as governments invest in modernizing infrastructure and boosting economic development.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Biological Drugs Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Biological Drugs by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Biological Drugs by Country/Region, 2019, 2023 & 2030
  • 2.2 Biological Drugs Segment by Type
  • 2.2.1 Therapeutic Protein
  • 2.2.2 Monoclonal Antibody
  • 2.2.3 Vaccine
  • 2.2.4 Others
  • 2.3 Biological Drugs Sales by Type
  • 2.3.1 Global Biological Drugs Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Biological Drugs Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Biological Drugs Sale Price by Type (2019-2024)
  • 2.4 Biological Drugs Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Ambulatory Surgical Centers
  • 2.4.3 Others
  • 2.5 Biological Drugs Sales by Application
  • 2.5.1 Global Biological Drugs Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Biological Drugs Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Biological Drugs Sale Price by Application (2019-2024)
  • 3 Global Biological Drugs by Company
  • 3.1 Global Biological Drugs Breakdown Data by Company
  • 3.1.1 Global Biological Drugs Annual Sales by Company (2019-2024)
  • 3.1.2 Global Biological Drugs Sales Market Share by Company (2019-2024)
  • 3.2 Global Biological Drugs Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Biological Drugs Revenue by Company (2019-2024)
  • 3.2.2 Global Biological Drugs Revenue Market Share by Company (2019-2024)
  • 3.3 Global Biological Drugs Sale Price by Company
  • 3.4 Key Manufacturers Biological Drugs Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Biological Drugs Product Location Distribution
  • 3.4.2 Players Biological Drugs Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Biological Drugs by Geographic Region
  • 4.1 World Historic Biological Drugs Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Biological Drugs Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Biological Drugs Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Biological Drugs Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Biological Drugs Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Biological Drugs Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Biological Drugs Sales Growth
  • 4.4 APAC Biological Drugs Sales Growth
  • 4.5 Europe Biological Drugs Sales Growth
  • 4.6 Middle East & Africa Biological Drugs Sales Growth
  • 5 Americas
  • 5.1 Americas Biological Drugs Sales by Country
  • 5.1.1 Americas Biological Drugs Sales by Country (2019-2024)
  • 5.1.2 Americas Biological Drugs Revenue by Country (2019-2024)
  • 5.2 Americas Biological Drugs Sales by Type
  • 5.3 Americas Biological Drugs Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Biological Drugs Sales by Region
  • 6.1.1 APAC Biological Drugs Sales by Region (2019-2024)
  • 6.1.2 APAC Biological Drugs Revenue by Region (2019-2024)
  • 6.2 APAC Biological Drugs Sales by Type
  • 6.3 APAC Biological Drugs Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Biological Drugs by Country
  • 7.1.1 Europe Biological Drugs Sales by Country (2019-2024)
  • 7.1.2 Europe Biological Drugs Revenue by Country (2019-2024)
  • 7.2 Europe Biological Drugs Sales by Type
  • 7.3 Europe Biological Drugs Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Biological Drugs by Country
  • 8.1.1 Middle East & Africa Biological Drugs Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Biological Drugs Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Biological Drugs Sales by Type
  • 8.3 Middle East & Africa Biological Drugs Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Biological Drugs
  • 10.3 Manufacturing Process Analysis of Biological Drugs
  • 10.4 Industry Chain Structure of Biological Drugs
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Biological Drugs Distributors
  • 11.3 Biological Drugs Customer
  • 12 World Forecast Review for Biological Drugs by Geographic Region
  • 12.1 Global Biological Drugs Market Size Forecast by Region
  • 12.1.1 Global Biological Drugs Forecast by Region (2025-2030)
  • 12.1.2 Global Biological Drugs Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Biological Drugs Forecast by Type
  • 12.7 Global Biological Drugs Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Bristol-Myers Squibb
  • 13.1.1 Bristol-Myers Squibb Company Information
  • 13.1.2 Bristol-Myers Squibb Biological Drugs Product Portfolios and Specifications
  • 13.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Bristol-Myers Squibb Main Business Overview
  • 13.1.5 Bristol-Myers Squibb Latest Developments
  • 13.2 Eli Lilly
  • 13.2.1 Eli Lilly Company Information
  • 13.2.2 Eli Lilly Biological Drugs Product Portfolios and Specifications
  • 13.2.3 Eli Lilly Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Eli Lilly Main Business Overview
  • 13.2.5 Eli Lilly Latest Developments
  • 13.3 Takeda
  • 13.3.1 Takeda Company Information
  • 13.3.2 Takeda Biological Drugs Product Portfolios and Specifications
  • 13.3.3 Takeda Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Takeda Main Business Overview
  • 13.3.5 Takeda Latest Developments
  • 13.4 Pfizer
  • 13.4.1 Pfizer Company Information
  • 13.4.2 Pfizer Biological Drugs Product Portfolios and Specifications
  • 13.4.3 Pfizer Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Pfizer Main Business Overview
  • 13.4.5 Pfizer Latest Developments
  • 13.5 Amgen
  • 13.5.1 Amgen Company Information
  • 13.5.2 Amgen Biological Drugs Product Portfolios and Specifications
  • 13.5.3 Amgen Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Amgen Main Business Overview
  • 13.5.5 Amgen Latest Developments
  • 13.6 F. Hoffmann-La Roche
  • 13.6.1 F. Hoffmann-La Roche Company Information
  • 13.6.2 F. Hoffmann-La Roche Biological Drugs Product Portfolios and Specifications
  • 13.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 F. Hoffmann-La Roche Main Business Overview
  • 13.6.5 F. Hoffmann-La Roche Latest Developments
  • 13.7 Johnson & Johnson
  • 13.7.1 Johnson & Johnson Company Information
  • 13.7.2 Johnson & Johnson Biological Drugs Product Portfolios and Specifications
  • 13.7.3 Johnson & Johnson Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Johnson & Johnson Main Business Overview
  • 13.7.5 Johnson & Johnson Latest Developments
  • 13.8 Merck
  • 13.8.1 Merck Company Information
  • 13.8.2 Merck Biological Drugs Product Portfolios and Specifications
  • 13.8.3 Merck Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Merck Main Business Overview
  • 13.8.5 Merck Latest Developments
  • 13.9 Abbott Laboratories
  • 13.9.1 Abbott Laboratories Company Information
  • 13.9.2 Abbott Laboratories Biological Drugs Product Portfolios and Specifications
  • 13.9.3 Abbott Laboratories Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Abbott Laboratories Main Business Overview
  • 13.9.5 Abbott Laboratories Latest Developments
  • 13.10 Baxter
  • 13.10.1 Baxter Company Information
  • 13.10.2 Baxter Biological Drugs Product Portfolios and Specifications
  • 13.10.3 Baxter Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 Baxter Main Business Overview
  • 13.10.5 Baxter Latest Developments
  • 13.11 Novartis
  • 13.11.1 Novartis Company Information
  • 13.11.2 Novartis Biological Drugs Product Portfolios and Specifications
  • 13.11.3 Novartis Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 Novartis Main Business Overview
  • 13.11.5 Novartis Latest Developments
  • 13.12 Biogen
  • 13.12.1 Biogen Company Information
  • 13.12.2 Biogen Biological Drugs Product Portfolios and Specifications
  • 13.12.3 Biogen Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.12.4 Biogen Main Business Overview
  • 13.12.5 Biogen Latest Developments
  • 13.13 GlaxoSmithKline
  • 13.13.1 GlaxoSmithKline Company Information
  • 13.13.2 GlaxoSmithKline Biological Drugs Product Portfolios and Specifications
  • 13.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.13.4 GlaxoSmithKline Main Business Overview
  • 13.13.5 GlaxoSmithKline Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Biological Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Biological Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Therapeutic Protein
Table 4. Major Players of Monoclonal Antibody
Table 5. Major Players of Vaccine
Table 6. Major Players of Others
Table 7. Global Biological Drugs Sales by Type (2019-2024) & (Units)
Table 8. Global Biological Drugs Sales Market Share by Type (2019-2024)
Table 9. Global Biological Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global Biological Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global Biological Drugs Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Biological Drugs Sales by Application (2019-2024) & (Units)
Table 13. Global Biological Drugs Sales Market Share by Application (2019-2024)
Table 14. Global Biological Drugs Revenue by Application (2019-2024)
Table 15. Global Biological Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global Biological Drugs Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Biological Drugs Sales by Company (2019-2024) & (Units)
Table 18. Global Biological Drugs Sales Market Share by Company (2019-2024)
Table 19. Global Biological Drugs Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Biological Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global Biological Drugs Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Biological Drugs Producing Area Distribution and Sales Area
Table 23. Players Biological Drugs Products Offered
Table 24. Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biological Drugs Sales by Geographic Region (2019-2024) & (Units)
Table 28. Global Biological Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global Biological Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Biological Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Biological Drugs Sales by Country/Region (2019-2024) & (Units)
Table 32. Global Biological Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global Biological Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Biological Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Biological Drugs Sales by Country (2019-2024) & (Units)
Table 36. Americas Biological Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas Biological Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Biological Drugs Revenue Market Share by Country (2019-2024)
Table 39. Americas Biological Drugs Sales by Type (2019-2024) & (Units)
Table 40. Americas Biological Drugs Sales by Application (2019-2024) & (Units)
Table 41. APAC Biological Drugs Sales by Region (2019-2024) & (Units)
Table 42. APAC Biological Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC Biological Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Biological Drugs Revenue Market Share by Region (2019-2024)
Table 45. APAC Biological Drugs Sales by Type (2019-2024) & (Units)
Table 46. APAC Biological Drugs Sales by Application (2019-2024) & (Units)
Table 47. Europe Biological Drugs Sales by Country (2019-2024) & (Units)
Table 48. Europe Biological Drugs Sales Market Share by Country (2019-2024)
Table 49. Europe Biological Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Biological Drugs Revenue Market Share by Country (2019-2024)
Table 51. Europe Biological Drugs Sales by Type (2019-2024) & (Units)
Table 52. Europe Biological Drugs Sales by Application (2019-2024) & (Units)
Table 53. Middle East & Africa Biological Drugs Sales by Country (2019-2024) & (Units)
Table 54. Middle East & Africa Biological Drugs Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Biological Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Biological Drugs Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Biological Drugs Sales by Type (2019-2024) & (Units)
Table 58. Middle East & Africa Biological Drugs Sales by Application (2019-2024) & (Units)
Table 59. Key Market Drivers & Growth Opportunities of Biological Drugs
Table 60. Key Market Challenges & Risks of Biological Drugs
Table 61. Key Industry Trends of Biological Drugs
Table 62. Biological Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Biological Drugs Distributors List
Table 65. Biological Drugs Customer List
Table 66. Global Biological Drugs Sales Forecast by Region (2025-2030) & (Units)
Table 67. Global Biological Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Biological Drugs Sales Forecast by Country (2025-2030) & (Units)
Table 69. Americas Biological Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Biological Drugs Sales Forecast by Region (2025-2030) & (Units)
Table 71. APAC Biological Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Biological Drugs Sales Forecast by Country (2025-2030) & (Units)
Table 73. Europe Biological Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Biological Drugs Sales Forecast by Country (2025-2030) & (Units)
Table 75. Middle East & Africa Biological Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Biological Drugs Sales Forecast by Type (2025-2030) & (Units)
Table 77. Global Biological Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Biological Drugs Sales Forecast by Application (2025-2030) & (Units)
Table 79. Global Biological Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Bristol-Myers Squibb Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol-Myers Squibb Biological Drugs Product Portfolios and Specifications
Table 82. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Bristol-Myers Squibb Main Business
Table 84. Bristol-Myers Squibb Latest Developments
Table 85. Eli Lilly Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Eli Lilly Biological Drugs Product Portfolios and Specifications
Table 87. Eli Lilly Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Eli Lilly Main Business
Table 89. Eli Lilly Latest Developments
Table 90. Takeda Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Biological Drugs Product Portfolios and Specifications
Table 92. Takeda Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Pfizer Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Biological Drugs Product Portfolios and Specifications
Table 97. Pfizer Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Amgen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Amgen Biological Drugs Product Portfolios and Specifications
Table 102. Amgen Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Amgen Main Business
Table 104. Amgen Latest Developments
Table 105. F. Hoffmann-La Roche Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. F. Hoffmann-La Roche Biological Drugs Product Portfolios and Specifications
Table 107. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. F. Hoffmann-La Roche Main Business
Table 109. F. Hoffmann-La Roche Latest Developments
Table 110. Johnson & Johnson Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Johnson & Johnson Biological Drugs Product Portfolios and Specifications
Table 112. Johnson & Johnson Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Johnson & Johnson Main Business
Table 114. Johnson & Johnson Latest Developments
Table 115. Merck Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Merck Biological Drugs Product Portfolios and Specifications
Table 117. Merck Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Merck Main Business
Table 119. Merck Latest Developments
Table 120. Abbott Laboratories Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Abbott Laboratories Biological Drugs Product Portfolios and Specifications
Table 122. Abbott Laboratories Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Abbott Laboratories Main Business
Table 124. Abbott Laboratories Latest Developments
Table 125. Baxter Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Baxter Biological Drugs Product Portfolios and Specifications
Table 127. Baxter Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Baxter Main Business
Table 129. Baxter Latest Developments
Table 130. Novartis Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Novartis Biological Drugs Product Portfolios and Specifications
Table 132. Novartis Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Novartis Main Business
Table 134. Novartis Latest Developments
Table 135. Biogen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Biogen Biological Drugs Product Portfolios and Specifications
Table 137. Biogen Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Biogen Main Business
Table 139. Biogen Latest Developments
Table 140. GlaxoSmithKline Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. GlaxoSmithKline Biological Drugs Product Portfolios and Specifications
Table 142. GlaxoSmithKline Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. GlaxoSmithKline Main Business
Table 144. GlaxoSmithKline Latest Developments
List of


Figure 1. Picture of Biological Drugs
Figure 2. Biological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Drugs Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Biological Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Biological Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Therapeutic Protein
Figure 10. Product Picture of Monoclonal Antibody
Figure 11. Product Picture of Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Biological Drugs Sales Market Share by Type in 2023
Figure 14. Global Biological Drugs Revenue Market Share by Type (2019-2024)
Figure 15. Biological Drugs Consumed in Hospitals
Figure 16. Global Biological Drugs Market: Hospitals (2019-2024) & (Units)
Figure 17. Biological Drugs Consumed in Ambulatory Surgical Centers
Figure 18. Global Biological Drugs Market: Ambulatory Surgical Centers (2019-2024) & (Units)
Figure 19. Biological Drugs Consumed in Others
Figure 20. Global Biological Drugs Market: Others (2019-2024) & (Units)
Figure 21. Global Biological Drugs Sales Market Share by Application (2023)
Figure 22. Global Biological Drugs Revenue Market Share by Application in 2023
Figure 23. Biological Drugs Sales Market by Company in 2023 (Units)
Figure 24. Global Biological Drugs Sales Market Share by Company in 2023
Figure 25. Biological Drugs Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Biological Drugs Revenue Market Share by Company in 2023
Figure 27. Global Biological Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Biological Drugs Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Biological Drugs Sales 2019-2024 (Units)
Figure 30. Americas Biological Drugs Revenue 2019-2024 ($ Millions)
Figure 31. APAC Biological Drugs Sales 2019-2024 (Units)
Figure 32. APAC Biological Drugs Revenue 2019-2024 ($ Millions)
Figure 33. Europe Biological Drugs Sales 2019-2024 (Units)
Figure 34. Europe Biological Drugs Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Biological Drugs Sales 2019-2024 (Units)
Figure 36. Middle East & Africa Biological Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Americas Biological Drugs Sales Market Share by Country in 2023
Figure 38. Americas Biological Drugs Revenue Market Share by Country in 2023
Figure 39. Americas Biological Drugs Sales Market Share by Type (2019-2024)
Figure 40. Americas Biological Drugs Sales Market Share by Application (2019-2024)
Figure 41. United States Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Biological Drugs Sales Market Share by Region in 2023
Figure 46. APAC Biological Drugs Revenue Market Share by Regions in 2023
Figure 47. APAC Biological Drugs Sales Market Share by Type (2019-2024)
Figure 48. APAC Biological Drugs Sales Market Share by Application (2019-2024)
Figure 49. China Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Biological Drugs Sales Market Share by Country in 2023
Figure 57. Europe Biological Drugs Revenue Market Share by Country in 2023
Figure 58. Europe Biological Drugs Sales Market Share by Type (2019-2024)
Figure 59. Europe Biological Drugs Sales Market Share by Application (2019-2024)
Figure 60. Germany Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Biological Drugs Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Biological Drugs Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Biological Drugs Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Biological Drugs Sales Market Share by Application (2019-2024)
Figure 69. Egypt Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Biological Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Biological Drugs in 2023
Figure 75. Manufacturing Process Analysis of Biological Drugs
Figure 76. Industry Chain Structure of Biological Drugs
Figure 77. Channels of Distribution
Figure 78. Global Biological Drugs Sales Market Forecast by Region (2025-2030)
Figure 79. Global Biological Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Biological Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Biological Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Biological Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Biological Drugs Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Biological Drugs Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.